针对CDK2进行癌症治疗.
Erik S Knudsen1, Agnieszka K Witkiewicz2, Ioannis Sanidas3
1Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Cell reports
|August 13, 2025
概括
向循环素依赖性激酶2 (CDK2) 提供了一个复杂但有前途的癌症治疗策略. 瘤遗传学和像环林E这样的生物标志物指导CDK2抑制剂的有效性和组合疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环素依赖激酶 (CDK) 是细胞循环的关键调节者,也是瘤学中重要的治疗点.
- 向CDK2与CDK4/6抑制剂相比,由于其独特的作用机制,具有独特的挑战和机会.
研究的目的:
- 探索针对CDK2进行癌症治疗的复杂性.
- 审查生物标志物在预测对CDK2抑制剂反应中的作用.
- 评估将CDK2抑制剂与其他药物类别结合的潜力.
主要方法:
- 对癌症治疗中CDK2抑制剂的最近研究的综述.
- 通过CDK2抑制调节的效应因子通路的分析.
- 检查影响治疗反应的遗传和表观遗传因素.
- 对生物标记数据 (例如,环林E,p16INK4A) 的评估,以确定CDK2抑制剂的疗效.
主要成果:
- CDK2抑制剂影响多个细胞循环阶段和效应因子通路.
- 瘤的遗传和表观遗传特征决定了对CDK2抑制剂的反应.
- 生物标志物如环林E和p16INK4A对于指导治疗至关重要.
- CDK2抑制剂显示出在各种瘤类型中有效的组合疗法的潜力.
结论:
- CDK2抑制是瘤学中复杂但可行的治疗策略.
- 生物标志物驱动的方法对于优化CDK2抑制剂使用至关重要.
- 需要进一步的研究来解决当前和正在开发的CDK2抑制剂的局限性和毒性.
相关概念视频
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Mitogens and the Cell Cycle
6.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K


